Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 03 Apr 2023
United States: The manufacturer announced FDA approval of GrayMatters Health's Prism, a non-invasive self-neuromodulation device for patients with post-traumatic stress disorder.
Read Full NewsAripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.
Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.
In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Health of Myeloma Patient's Marriage Tied to Recovery After Transplant
3.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
4.
In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.
5.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
1.
Target-Mediated Drug Disposition in Hematologic Therapeutics
2.
Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics
3.
Clinical Models in Oncology for Modern Medicine
4.
Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars
5.
Artificial Intelligence for Spatial Tumor Evolution Reconstruction
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge